Yuandong Hu

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 7 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Centaurus Biopharma Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuandong Hu. Retrieved from https://idiyas.com/inventor/yuandong-hu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 73.3

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 13 (Patent Applications = 16)

Average Co-Inventor Count = 11.6

ph-index = 5

Forward Citations = 53(Granted Patents)

Company Filing History:

14 out of 33

Centaurus Biopharma Co., Ltd.

patents

12 out of 121

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

patents

10 out of 26

Lianyungang Runzhong Pharmaceutical Co., Ltd.

patents

4. 1 out of 1

Centaurus Biophrama Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2016-2021

Loading Chart...

Areas of Expertise:

Iridinesulfonamide

Sultam Compound

Neurotrophic Factor

CDK Inhibitor

Pyrrolopyrimidine

EGFR Inhibitor

Bruton's Tyrosine Kinase

Quinazoline Derivative

Protein Kinase Inhibitor

MEK Inhibitors

FAK/Pyk2 Inhibitors

Selective Estrogen Receptor Modulators

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11203586 - Iridinesulfonamide compound and use method thereof (2021-12-21),

2. 11111240 - Sultam compound and application method thereof (2021-09-07),

3. 10829492 - Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor (2020-11-10),

4. 10745383 - 1,3,5-triazine derivative and method of using same (2020-08-18),

5. 10570141 - Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof (2020-02-25),

6. 10561657 - Pyrrolopyrimidine compound (2020-02-18),

7. 10329277 - N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity (2019-06-25),

8. 10155722 - Antitumor compound targeting IDH2 mutation and method of use thereof (2018-12-18),

9. 9926299 - Inhibitors of bruton's tyrosine kinase (2018-03-27),

10. 9725439 - Quinazoline derivative and preparation method therefor (2017-08-08),

11. 9708295 - Substituted 2-aminopyridine protein kinase inhibitor (2017-07-18),

12. 9550781 - Kinase modulating compounds, compositions containing the same and use thereof (2017-01-24),

13. 9540396 - 6-arylamino pyridone carboxamide as MEK inhibitors (2017-01-10),

14. 9428508 - 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors (2016-08-30),

15. 9309211 - Arylalkene derivatives and use thereof as selective estrogen receptor modulators (2016-04-12),

Title: Yuandong Hu - Innovator from Beijing, CN

Introduction: Yuandong Hu is a renowned inventor based in Beijing, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yuandong Hu holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his expertise in cutting-edge technologies.

Career Highlights: With a career spanning over two decades, Yuandong Hu has worked with leading tech companies, research institutions, and universities, playing a pivotal role in developing advanced solutions for complex challenges.

Collaborations: Throughout his career, Yuandong Hu has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge sharing.

Conclusion: Yuandong Hu's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and researchers globally.

Profile summary based on public USPTO records.